Adel G Bishai, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 6 Doctors Dr, Emporia Medical Associates Pc, Emporia, VA 23847 Phone: 434-634-6101 |
News Archive
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
Chimeric antigen receptor T-cell therapy, or CAR T, was named the 2017 Advance of the Year by the American Society of Clinical Oncology. The FDA approved two CAR T products last year for treatment of adult large B-cell lymphoma based on the exceptional patient outcomes seen in clinical trials.
A student at the Queensland University of Technology (QUT) in Brisbane has been diagnosed with tuberculosis (TB) and as a result 160 staff and students at the University are being screened for the disease.
Mayo Clinic today announced that it has entered into a multiyear agreement with Wuhan Kindstar Globalgene Technology, Inc. (Kindstar) to provide specialized laboratory support based on provision of knowledge from Mayo Clinic's Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Medical Laboratories.
Lucrative opportunities await manufacturers in the European wireless patient monitoring devices market, particularly in the wireless assisted living devices segment. This segment is growing at a rapid pace. The primary reason for this growth is rising awareness levels among an ageing population about devices that help in attaining a better standard of life.
› Verified 9 days ago